Skip to main content
. Author manuscript; available in PMC: 2019 Dec 1.
Published in final edited form as: Cancer. 2018 Oct 11;124(23):4467–4476. doi: 10.1002/cncr.31662

Figure 2:

Figure 2:

Summary of the expected (or intended) first year of enrollment of study trials extracted from the clinicaltrials.gov registry and WHO. Gold color indicates the total number of phase III clinical trials, dark blue color indicates the total number of phase II clinical trials, and light blue indicates the total number of phase I or phase I/II clinical trials.